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Abstract
Traditional Chinese medicine encompasses a rich empirical knowledge of the use of plants for the treatment of disease. In
addition, the microorganisms associated with medicinal plants are also of interest as the producers of the compounds
responsible for the observed plant bioactivity. The present study has pioneered the use of genetic screening to assess the
potential of endophytes to synthesize bioactive compounds, as indicated by the presence of non-ribosomal peptide
synthetase (NRPS) and polyketide synthase (PKS) genes. The total DNA extracts of 30 traditional Chinese herbs, were
screened for functional genes involved in the biosynthesis of bioactive compounds. The four PCR screens were successful in
targeting four bacterial PKS, six bacterial NRPS, ten fungal PKS and three fungal NRPS gene fragments. Analysis of the
detected endophyte gene fragments afforded consideration of the possible bioactivity of the natural products produced by
endophytes in medicinal herbs. This investigation describes a rapid method for the initial screening of medicinal herbs and
has highlighted a subset of those plants that host endophytes with biosynthetic potential. These selected plants can be the
focus of more comprehensive endophyte isolation and natural product studies.
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Introduction
There is an ongoing need for novel drugs that are highly
effective in the treatment of cancer, drug resistant bacteria, fungal
infections, emerging viruses and parasitic protozoan infections.
Historically, natural products have provided the basis for the
majority of new drugs and the bioactive properties of a wide
variety of flora is reflected in their continued roles in the
traditional healthcare systems of many cultures [1]. The successful
use of plants in traditional medicine and modern natural products
research has meant that there is a renewed interest in exploiting
various aspects of the underlying bioactivities.
Still widely practiced in the modern era, Traditional Chinese
Medicine (TCM) can trace its origins back thousands of years, to
the dawn of civilisation in China. TCM theory is based on
experiences of the effects of the medicines through documented
trials to establish knowledge of the use of plants (approximately
5000 species) for the treatment of many diseases [2]. This TCM
background has provided the basis for the discovery of several
therapeutic agents, including the anticancer agents indirubin [3],
camptothecin [4] and harringtonine [5]; aretemisinin (antimalar-
ial) [6] and ephedra (central nervous system stimulant) [7].
Compounds isolated from plant preparations are largely the
products of plant metabolism, however, microorganisms living in
symbiosis with plants also produce bioactive compounds. Taxol
and camptothecin are examples of anticancer compounds
synthesized by both plants and endophytes [8,9]. In their natural
environment the internal tissues of plants are frequently colonized
by numerous different microorganisms, termed endophytes. Many
endophytes produce secondary metabolites which confer major
ecological benefits to their host plants including plant growth
promotion [10], enhanced resistance to various predators and
pathogens [11,12], and increased drought resistance [13].
Consequently, endophyte derived metabolites may also cause the
observed bioactivity and associated beneficial health claims of the
TCM host plants [14].
Low molecular weight endophytic secondary metabolites
demonstrate a large degree of structural diversity with the largest
and most important groups of compounds including the polyke-
tides, amino acid derived compounds, and terpenes [15]. To date
genetic methods have been used to screen for biosynthetic
pathways involved in secondary metabolism. Genetic screening
for microbial natural product genes has largely focused on the
detection of the polyketide and non-ribosomal peptide synthesis
pathways [16,17].
Polyketides are produced by many fungi, bacteria, plants and
marine organisms [15]. This large family of structurally diverse
natural products have already found widespread application as
pharmaceuticals including rapamycin (immunosuppressant),
erythromycin (antibiotic), lovastatin (anticholesterol drug), and
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epothilone B (anticancer drug). Polyketides are biosynthesized by
large multimodular enzyme complexes termed polyketide synthas-
es (PKSs) which catalyse the polymerisation of acyl-CoA thioester
building blocks [18]. PKSs are typically categorized based on their
number of subunits (single or multiple) and their mode of synthesis
(iterative or modular). The best characterized group of PKSs are
the type I PKSs with a single enzyme complex responsible for the
biosynthesis of the polyketide backbone. They can be either
modular as found in bacteria, or iterative as found in fungi [19].
Extension of the polyketide backbone requires three core PKS
domains: an acyltransferase (AT) domain, acyl carrier proteins
(ACP) domain and a ketosynthase (KS) domain. The modular
structure of type I PKSs and their assembly of polyketides,
resembles the organisation of non-ribosomal peptide synthetases
(NRPSs) and the production of non-ribosomal peptides.
Complex oligopeptides are formed by NRPSs through the linear
condensation of proteinogenic and non-proteinogenic amino
acids. NRPSs are involved in the biosynthesis of compounds
including penicillin and cephalosporin (antibiotics), cyclosporine A
(anti-inflammatory and immunosuppressive activities, and the
endophyte-produced fusaricidin (antibiotic). NRPSs are composed
of a series of modules, each containing the catalytic units required
for the recognition, activation and peptide bond formation of the
growing peptide chain by adenylation (A), thiolation (T), and
condensation (C) domains, respectively [20]. NRPSs are found in
bacteria and fungi feature the three core domains arranged in the
order C-A-T [20].
While mechanistically distinct, the highly conserved regions
within the KS and A domains are logical targets for the detection
of PKS and NRPS biosynthesis genes, respectively. This facilitates
the design of degenerate oligonucleotide primers, suitable for
genetic screening of secondary metabolism pathways [21,22,23].
The location of host plants can affect endophyte populations
[24,25] and for drug discovery potential it is imperative to
investigate TCM plants sampled from their natural environment
or those cultivated for medicinal purposes. Considering this, plant
collections from Yunnan province were selected for two main
reasons. Firstly, Yunnan is recognized for its large botanical
diversity [26] and secondly, it is a source of many pharmaceutical
herbs. TCM herbs with reported anticancer activity were chosen
in an effort to increase the likelihood of discovering endophyte
produced anticancer compounds [2].
The aim of this study was to assess the use of genetic screening
for the identification of plant leads for endophyte natural product
investigations. The biosynthetic potential of endophytes was
considered via the detection of endophyte PKS and NRPS
biosynthesis genes. Total DNA from thirty selected anticancer
TCM herbs was genetically screened using four PCR primers sets.
This study has identified a subset of TCM herbs found to harbor
endophytes with bioactive potential, and these plants can be
targeted in future investigations. The use of this genetic screen
increases the likelihood of isolating endophytes which biosynthe-
size novel pharmaceuticals independently of the host plant.
Methods
Selection, collection and storage of TCM herbs
Yunnan province is situated in the southwestern region of the
People’s Republic of China. There is a strong temperature
gradient across the province and it contains areas of permanent
snow as well as rainforests with temperatures perennially above
10uC [26]. Thirty plant tissue samples (Table 1) were collected
during spring in April.2007 from sites within and surrounding
Kunming City. No specific permits were required, however, the
collections were acknowledged and supported by the Yunnan
Provincial government. Potential anticancer TCM herbs were
selected based on scientific and traditional literature, their
maturity for use as TCMs and their availability for collection at
the time of collection. Following collection, samples were placed in
sterile bags and stored in the dark at 4uC until processed.
Processing was completed as soon as possible following receipt of
samples, usually within 24 h.
Surface sterilisation of plant samples
Sections of each plant were carefully washed in running water to
remove external soil and debris. Samples were examined to
exclude those that showed symptoms of disease or superficial
damage. In a method adapted from Cankar et al. [27], plant
material was surface sterilized by immersion in 30% hydrogen
peroxide for 30 min, followed by rinsing in sterile Milli-Q filtered
water (Millipore) and washing with 70% ethanol for 1 min [27].
To confirm that the surface sterilisation process was successful, a
section of each sterilized plant was placed into an aliquot of heart
infusion broth and incubated at 30uC for three days before
examining the media for any growth of plant surface-associated
contaminating microorganisms.
DNA extraction
The different tissue types collected from the one plant were
processed together for the total DNA extract. Total genomic DNA
was extracted from the surface sterilized plant samples using the
Power Plant DNA isolation kit (MoBio Laboratories). Extracted
DNA consisted of host plant nuclear and plastid DNA and any
endophyte microbial DNA. Extracted DNA was run on an agarose
gel and NanoDrop (Thermo Scientific) readings taken to assess
concentration and purity. Working stocks of DNA extracts were
diluted to 1–10 ng/mL for PCR assays.
Polymerase Chain Reaction
DNA extracts from TCM plants were screened using PCR
primers that targeted various plant, bacterial and fungal genes.
The PCR targets and primers employed in this investigation
(NRPS, PKS, and the plant RUBISCO genes) are listed in Table 2.
Typical gene-specific PCR reactions were carried out in 20 ml
reaction volumes that contained 16reaction buffer (Bioline),
2.5 mM MgCl2, 0.2 mM dNTPs (Bioline), 10 pmol each of
forward and reverse primers (Sigma-Aldrich, MO, USA), 0.2 U
Taq DNA polymerase (Bioline) and 1–10 ng of DNA template.
Thermal cycling was performed in a MyCycler Thermal Cycler
(BioRad), with an initial denaturation at 94uC for 5 min, followed
by 30 cycles of 94uC for 30 s, 55uC for 30 s, and 72uC for 1 min,
followed by a final extension step at 72uC for 7 min. Degenerate
PCRs were also performed in 20 mL reaction volumes containing
the same reaction mix as for the non-degenerate primers except
that 25 pmol of forward and reverse primers were used and the
number of amplification cycles was increased to 35. PCR
amplicons were separated by agarose gel electrophoresis in TAE
buffer (40 mM Tris-acetate, 1 mM EDTA, pH 7.8), visualized by
ethidium bromide staining (0.5 mg /ml) and the GelDoc UV
transilluminator (BioRad).
A spiked PCR targeting the conserved plant RUBISCO gene
was used to ensure the absence of PCR inhibitors in the DNA
samples. This procedure involved two PCRs per DNA sample, the
first containing both sample DNA and an inhibitor free control
DNA and the second reaction contained only sample DNA. Lack
of amplification in control-spiked reactions was likely to be due to
PCR inhibitors in the sample DNA. In this event, DNA was
diluted to an extent where the PCR reaction was not inhibited.
Biosynthetic Potential of TCM Herb Endophytes
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The second PCR reaction, containing only sample DNA, was used
to ensure that DNA was not diluted beyond the PCR detection
limits.
DNA sequencing
PCR amplicons, of the correct size, were purified directly by
ethanol precipitation or gel purification using the UltraClean
GelSpin DNA Extraction Kit (MoBio Laboratories) in accordance
with the manufacturer’s instructions.
Amplicons were sequenced using the PRISM BigDyeTM cycle
sequencing system v3.1 on an ABI PRISM 373 DNA Sequencer
(Life Technologies, Carlsbad, USA). PCR products that contained
multiple sequences, as observed by multiple peaks in the
sequencing chromatograms, were cloned using the TOPO cloning
vector (Invitrogen Life Technologies, Carlsbad, USA), trans-
formed into Escherichia coli DH5a and a clone library established
according to the manufacturer’s instructions. Thereafter, colony
PCR screening and DNA sequencing of cloned inserts was
performed to characterize single amplicons. Sequences were
deposited into GenBank.
Phylogenetic analysis of KS and NRPS fragments
Sequence data were compared to the NCBI dataset on
GenBank with the BLASTX algorithm (http://blast.ncbi.nlm.
nih.gov/Blast.cgi). The amino acid substrates recognized by the A
domain binding pockets were predicted using the NRPSpredictor
analysis tool available at (http://www-ab.informatik.uni-
tuebingen.de/toolbox/index.php?view= domainpred) [28]. Mul-
tiple sequence alignments of KS and A domain protein sequences
of PKS or NRPS pathways, respectively, were generated using
Table 1. Traditional Chinese medicinal herbs collected for genetic screening.
Host Plant Species Location Plant Sample Pharmacological or TCM Activity Reference
Aconitum carmichaeli Debx. Countryside Leaf and root Sedative, analgesic, antiinflammatory,
anticancer, toxic
[65]
Actinidia chinensis Planch. Medicinal herb farm Root and stem ‘‘Heat clearing’’, antimutagenic, anticancer [66]
Agrimonia pilosa Ledeb. var. japonica (miq.)
Nakai
Medicinal herb farm Above ground Haemostatic, antiinflammatory, antiinfective [2]
Artemisia capillaris Thunb. Medicinal herb garden Leaf and stem ‘‘Heat clearing’’, antihepatotoxic, antibacterial,
antiinflammatory
[2]
Astilbe rivularis Buch.-Ham. Medicinal herb garden Whole plant Antiviral [67]
Belamcanda chinensis (L.) DC. Medical herb farm Root Antifungal, antiviral, antiinflammatory, diuretic [2]
Bletilla striata (Thunb.) Reichp. Medical herb farm Root/bulb Haemostatic, anticancer [2]
Cephalotaxus fortunei Hook. F. Countryside Leaf and stem Anticancer [68]
Clematis hexapetala Pall. Medicinal herb farm Root Antibacterial, antifungal [2]
Coptis chinensis Franch. Medicinal herb farm Root Antibacterial, antiinflammatory, affects central
nervous system
[2]
Dendrobium nobile, Lindl. Countryside Stem Anticancer, antimutagenic [69]
Digitalis purpurea Ehrh. Medicinal herb garden Root Cardiotonic, anticancer [70]
Eleutherococcus senticosus (Rupr. & Maxim) Maxim Medicinal herb farm Root Anticancer, expectorant [71]
Leonurus heterophyllus Sweet Medicinal herb farm Above ground Anticancer, ‘‘invigorates blood’’ [68]
Lithospermum erythrorhizon Sieb.et Zucc. Medicinal herb farm Root Anticancer, antibacterial, antiinflammatory [2]
Lonicera japonica Thunb. Countryside Leaf Antiinfective [2]
Lycium chinense Mill Medicinal herb garden Branch and leaf Anticancer, immune stimulating [68]
Pinellia ternata (Thunb.) Breit. Countryside Root Anti-emetic, mucolytic, anticancer (cervical),
discutient
[65]
Pinellia pedatisecta Schott Medicinal herb farm Root Toxic, anticancer [66]
Paris polyphylla Smith var. chinensis (Franch.) Hara Medicinal herb farm Root and leaf Antiinflammatory, detoxicant, anticancer [66]
Rheum palmatum L. Medicinal herb farm Root Anticancer, detoxicant,
antiinflammatory, laxative
[2]
Rubia cordifolia L. Countryside Leaf and root Antiinflammatory, antiviral [72]
Salvia przewalskii Maxim Medicinal herb farm Root Anticancer, immune stimulating, antioxidant [73]
Salvia yunnanensis C.H. Wright Medicinal herb farm Root Anticancer, immune stimulating [73]
Senecio scandens Buch.-Ham. Ex D. Countryside Leaf and root Antiinflammatory, anticancer, detoxicant,
antibacterial
[68]
Solanum nigrum L. Countryside Leaf and root Antimicrobial [68]
Sophora davidii (Franch) Kom. Ex Pavol. Medicinal herb garden Leaf and root Anticancer, antiinflammatory [74]
Sophora japonica L. Countryside Leaf and stem Hemostatic [68]
Taxus baccata L. Countryside Leaf and stem Anticancer [75]
Thalictrum foliolosum DC Medicinal herb garden Leaf and root Anticancer, antiinfective, antihypertensive [74]
doi:10.1371/journal.pone.0035953.t001
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ClustalX [29] (Figure S1). Gaps and positions with ambiguities
were excluded from the phylogenetic analysis. The ProtTest
program was used to determine the most appropriate substitution
model for the dataset [30]. Phylogenetic analysis was performed
using the maximum likelihood methods [31]. Node support values
were determined by the approximate Likelihood-Ratio Test
(aLRT).
Results
Identification of genes encoding bioactivity in TCM
plants
The total DNA extracted from thirty TCM plants was expected
to contain a mixture of plant and endophyte genes. The DNAs
were free from PCR inhibitors, as evidenced by successful PCR
amplification of the plant RUBISCO gene. Degenerate PCRs
were used to detect putative NRPS and PKS gene sequences
originating from bacterial and fungal endophytes in the DNA
extracts. Specifically, the PCR screens were successful in targeting
endophyte sequences with four streptomycete KS, six streptomy-
cete A, ten fungal KS and three fungal A domain genes detected
(Table 3). Some of the amplified PKS and NRPS PCR products
could be directly sequenced, however, many contained a mixture
of amplicons that needed to be cloned into a TOPO cloning
vector. In such cases, at least ten transformants were randomly
selected for direct colony PCR and the products sequenced.
Amplification of bacterial and fungal A domains and KS domains
was confirmed via sequencing and BLASTX (translated) analysis
(Table 3). BLASTN (nucleotide) analysis of the PCR products did
not reveal any significant matches to the nucleotide database,
indicating that the sequences were novel at this level. Endophyte-
derived genes were amplified from DNA extracted from different
types of plant tissues including the roots, leaves, stems and bark
(Table 1).
Ten unique fungal KS domain sequences (,700 bp) were
amplified from total DNA extracts of Bl. striata, C. fortunei, L.
heterophyllus, Lo. japonica, P. ternata, S. scandens, and T. baccata
(Table 3). The amplified sequences possessed between 76% and
100% amino acid identity to known fungal PKSs. Specifically,
sequence LH2 shared 100% sequence identity with an unchar-
acterized PKS from Botryotinia fuckeliana. Other fungal PKS
amplicons were similar to genes involved in the production of
polyketides, such as melanin and the toxic pigment elsinochrome.
Table 2. PCR primers and reaction conditions used in the screening of total DNA extracts from TCM plants.
Target Primer
Primer Sequence
(59R39)
Product
size (bp)
Altered* reaction
conditions
Altered*
thermocycling
conditions Reference
Plant RUBISCO
enzyme
rbcL-F tgtcaccacaaacagarackaa ,1400 [76]
rbcL-R caaaattaaatmsgatctctttccatac
Adenylation domain,
Bacterial NRPSs
MTF2 gcnggyggygcntaygtncc ,1000 94uC for
10 s, 52uC for
30 s, 72uC for 30 s
[77]
MTR2 ccncgdayttnacytg
Ketosynthase domain,
Bacterial PKSs (Type 1)
DKF gtgccggtnccrtgngyytc ,650–700 [41]
DKR gcgatggayccncarcarmg
Adenylation domain,
Fungal NRPSs
RJ016-R arrtcnccngtyttrta ,300 94uC for 30 s, 50uC
for 30 s, 60uC for
1 min; final extension:
60uC for 10 min
[78]
RJ016-F tayggnccnacnga
Ketosynthase domain,
Fungal PKSs (Type 1)
LC1 gayccimgittyttyaayatg ,700 Primers
(pmol): LC1,
50; LC2c, 8; LC3,
24; LC5c,
16
94uC for 30 s, 56uC
for 10 s,
72uC for 30 s
[79]
LC2c gticcigticcrtgcatytc
LC3 gcigarcaratggayccica ,700
LC5c gtigaigticrtgigcytc
Adenylation domain,
Streptomycete NRPSs
A3F gcstacsysatstacacstcsgg ,700 10 pmol each
primer, 0.25 mM
dNTPs,
10% DMSO
94uC for 30 s, 58uC
for 1 min, 72uC
for 2 min
[33]
A7R sasgtcvccsgtscggtas
Ketosynthase domain,
Streptomycete PKS
(Type 1)
K1F tsaagtcsaacatcggbca ,120021400 20 pmol each primer,
0.25 mM dNTPs,
10% DMSO
94uC for 30s, 55uC for
min, 72uC
for 3 min
[33]
M6R cgcaggttscsgtaccagta
*Altered from standard PCR procedures described.
doi:10.1371/journal.pone.0035953.t002
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Screening of total TCM plant DNA successfully amplified
,300 bp fragments of the fungal NRPS A domain. Of all the
DNAs screened only DNA from Pi. pedatisecta produced NRPS
gene fragments (PPe1, PPe2, PPe3). BLASTX analysis revealed
that the predicted translated DNA sequences were homologous to
bacterial NRPSs, with sequence similarity between 58% and 68%.
Prediction of the eight amino acids that form the A domain active
site, and the amino acids that bind to the active residues, was not
Table 3. PKS and NRPS genes identified with degenerate PCR primers.
Gene Plant
Sequence
identifier BLASTX Match Identity (%)
Accession
number
Predicted binding
pocket (amino acid
substrate)1,2
Fungal PKS Bl. striata BS1 Elsinochrome PKS,
Elsinoe fawcettii
124/161
(77%)
ABU63483 ND
Fungal PKS C. fortunei CF1 PKS involved in melanin
production, Bipolaris oryzae
189/210
(90%)
BAD22832 ND
Fungal PKS L. heterophyllus LH1 non-reduced type PKS
for melanin pigment,
Ascochyta rabiei
232/236
(98%)
ACS74449 ND
Fungal PKS L. heterophyllus LH2 Uncharacterized PKS,
Botryotinia fuckeliana
221/221
(100%)
AAR90249 ND
Fungal PKS Lo. japonica LJ1 Putative non-reduced
type PKS, Penicillium sp.
193/207
(93%)
ABQ85550 ND
Fungal PKS P. ternata PT1 Conidial pigment PKS,
Verticillium albo-atrum
197/211
(93%)
EEY14472 ND
Fungal PKS S. scandens SS1 PKS 1, Glarea lozoyensis 198/220
(90%)
AAN59953 ND
Fungal PKS S. scandens SS2 Putative melanin PKS,
Penicillium sp.
205/243
(98%)
ACJ13039 ND
Fungal PKS S. scandens SS3 PKS 1, Glarea lozoyensis 205/243
(84%)
AAN59953 ND
Fungal PKS T. baccata TB1 Elsinochrome PKS, Elsinoe
fawcettii
205/243
(84%)
ABU63483 ND
Fungal NRPS Pi. pedatisecta PPe1 MicC synthetase,
Planktothrix rubescens
20/34
(58%)
CAQ48260 No prediction
Fungal NRPS Pi. pedatisecta PPe2 AerB synthetase,
Planktothrix rubescens
56/95 (58%) CAQ48266 No prediction
Fungal NRPS Pi. pedatisecta PPe3 Arthrofactin synthetase,
Burkholderia ghumae
65/95
(68%)
YP_002908545 No prediction
Bacterial PKS D. purpurea DL1 Nystatin synthase (NysC)
Streptomyces halstedii
103/174
(59%)
AAF71776 ND
Bacterial PKS Pa. polyphylla PPol1 NapC synthase Streptomyces
hygroscopicus
157/218
(72%)
ABB86421 ND
Bacterial PKS Pa. polyphylla PPol2 NapC synthase Streptomyces
hygroscopicus
166/235
(70%)
ABB86421 ND
Bacterial PKS Pi. pedatisecta PPe4 Arthrofactin synthetase,
Pseudomonas sp. MIS38
47/63 (74%) BAC67535 ND
Bacterial NRPS D. purpurea DL2 Peptide synthetase PhsB,
Streptomyces
viridochromogenes
83/130
(63%)
CAJ14037 DVEHLSLID- (pro)
Bacterial NRPS D. purpurea DL3 Ansamitocin PKS,
Actinosynnema pretiosum
121/231
(52%)
AAM54075 -AFALACGM- (val/leu/ile/
abu/iva)
Bacterial NRPS L. heterophyllus LH3 Amino acid adenylation
domain Acidovorax avenae
18/19
(94%)
YP_972054 DVWNIGLI(thr)
Bacterial NRPS L. heterophyllus LH4 Pyoverdine synthetase,
Pseudomonas fluorescens
154/181
(85%)
AAF40219 CVWHFGRI (glu)
Bacterial NRPS B. chinensis BC1 Amino acid adenylation
domain, Rhodococcus
erythropolis
192/195
(98%)
ZP_04387369 DATFAGGI (leu/ile/val)
Bacterial NRPS B. chinensis BC2 Amino acid adenylation
domain, Rhodococcus
erythropolis
224/228
(98%)
ZP_04387369 DATFAGGI (leu/ile/val)
1In silico prediction of the amino acid substrate recognized by putative NRPS fragments [28].
2ND= not done.
doi:10.1371/journal.pone.0035953.t003
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successful possibly indicating that the algorithm is not sufficiently
robust to predict fungal NRPS module specificity [32].
Bacterial directed primers were also used to screen for PKS and
NRPS genes [33]. Degenerate primers targeting the genes coding
for the KS domain of actinobacterial PKSs amplified a total of
four unique amplicons from the plant DNA extracts, including D.
purpurea (one), P. polyphylla (two), and P. peditasecta (one). Predicted
translation of the gene fragments was afforded through the
BLAST program and subsequent peptide sequence analysis
established that three of the fragments were similar to sequences
of PKSs involved in the biosynthesis of the antifungal compound
nystatin (DL1, 59%) and the anticancer and antibiotic compound
geldanamycin (PPo1, 72% and PPo2, 70%). The sequence of PPe4
was shorter (,235 bp) and had 74% similarity to arthrofactin
synthetase from Pseudomonas sp. MIS38 (Table 3).
Screening of the TCM plant DNA extracts for bacterial NRPS
A domain gene sequences revealed six unique amplicons from the
extracts of D. purpurea, L. heterophyllus and B. chinense. The translated
sequences of five of these amplicons showed high sequence
similarity, 57–98%, to bacterial NRPS synthetases (Table 3).
Importantly, amplicons BC1 and BC2 showed significant similar-
ity (98%) to an adenylation domain of an uncharacterized
Rhodococcus erythropolis NRPS. Of relevance to drug discovery, the
product amplified from D. purpurea (DL3) had 65% sequence
similarity to the ansamitocin synthase from Actinosynnema pretiosum.
Unlike the PKS amplicons, which were all similar to published
Streptomyces sp. sequences, the NRPS PCR amplicons were similar
to sequences of diverse bacteria, including the Proteobacteria and
different genera of the Actinobacteria group (Table 3).
The deduced translated A domains sequences were analysed to
determine if they contained an eight residue binding pocket, and
the amino acid that was likely to be bound by the pocket.
Predictions were successful for the bacterial NRPS sequences
including fragments BC1 and BC2 that are likely to possess the
same amino acid binding pocket, and could bind either a Leu, Ile
or Val residue (Table 3). Analysis of the two fragments detected
from the endophytes of L. heterophyllus, LH3 and LH4, were shown
to possess different binding pockets and thus would be involved in
the addition of different amino acids to the growing peptide chain
produced by the NRPS (Table 3).
Phylogenetic distribution of PKS and NRPS genes from
TCM endophytes
In an attempt to investigate the homology and novelty of
amplicons from the genetic screen, the deduced amino acid
sequence of the KS and A domain gene fragments were used in
multiple sequence alignments and the phylogenies reconstructed.
The unrooted phylogenetic tree of fungal PKSs (Figure 1) revealed
the presence of two main clades that correspond to the two largest
structural classes of fungal polyketides: reduced and unreduced. All
fungal KS domain sequences amplified in this study belonged to
the clade of PKSs which synthesize unreduced PKs. The proteins
were closely grouped to PKSs involved in the biosynthesis
pathways of various pigments including melanin (LH1, PT1),
other pigments from Penicillium sp. and Elsinoe fawcetti (CF1, LJ1,
SS2), or putative PKSs derived from endophytes and other fungal
symbionts (BS1, LH2, SS1, SS3, PT1). The gene products of SS1
and SS3 formed a highly supported clade and are possible
homologs of the same biosynthetic pathway.
Phylogenetic analysis was performed on the inferred amino acid
sequences of NRPS A domains (Figure 2). The three NRPS A
domains sequences identified in this study were amplified from the
extract of Pi. pedatisecta and although each sequence was unique,
the sequences (PPe1, PPe2 and PPe3) were clustered in the
phylogenetic tree indicating that they most probably have a
common phylogenetic ancestor and/or similar function. This
cluster of fragments also grouped with cyanobacterial NRPSs.
Related NRPSs included those involved in the synthesis of a range
of bioactive compounds; MicC in the synthesis of the pentapeptide
microginin in Planktothrix rubescens [34], AerB in the synthesis of the
aeruginosin protease inhibitors in Microcystis viridis [35], and OciA
in the synthesis of cyanopeptolin [36]. Despite the fact that fungal
specific PCR primers were used, these A domain sequences had
greater similarity to NRPSs of bacterial origin with bacterial and
fungal NRPSs clustered separately in the phylogenetic tree
(Figure 2).
Phylogenetic analysis of inferred bacterial KS domains revealed
that the endophyte sequences clustered with KS domains of
Actinobacteria (Figure 3). Sequences PPol1 and PPol2 were closely
related to each other and also clustered with PKS fragments
involved in the biosynthesis of the anticancer antibiotic geldana-
mycin, from Streptomyces hygroscopicus [37]. The DL1 sequence
clustered within a clade containing KS domains, involved in the
tailoring of geldanamycin and herbimycin in S. hygroscopicus, and
an uncharacterized KS domain from Pseudonocardia autotrophica.
The sequence PPe4 was not included in the bacterial PKS multiple
sequence alignment and phylogenetic tree, because it was
significantly shorter than the other fragments (,80 amino acids).
The phylogenetic tree containing bacterial NRPS A domain
sequences demonstrated two main clusters from the Actinobac-
teria and Proteobacteria (Figure 4). Sequences BC1 and BC2 were
closely related and clustered with an uncharacterized NRPS
biosynthesis pathway from Rhodococcus erythropolis. Although the
function of the R. erythropolis NRPS is unknown, it also grouped
with A domain sequences from other Actinobacteria. Sequences
LH3 and LH4 were related to NRPS sequences from the
Proteobacteria, specifically Pseudomonas fluorescens and Acidovorax
avenae, respectively. The sequences DL3 grouped with the clade of
bacterial A domain sequences, however, had low homology to
known NRPSs.
Discussion
Natural product drug discovery investigations are supported by
a vast number of candidate systems and environments available for
study, presenting the necessity to optimise the targets chosen for
investigation. Ethnopharmocological approaches have been af-
firmed by the discovery of novel bioactive compounds from
traditional medicinal plants [3,6,38]. Additionally endophytes are
capable of producing a wide variety of natural products,
contributing to the overall bioactivity of the host plant. Thus,
they are considered to be a valuable source of novel bioactive
compounds and an avenue to increase the breadth of natural
product studies [39]. The present study took advantage of the
immense knowledge of TCM plants to focus on plants of
pharmaceutical interest. This preliminary study screened the
metabolic potential of endophytes using PKS and NRPS genes as
a proxy for endophytic production of bioactive compounds. The
use of these genes reflects the noted involvement of PKSs and
NRPSs in the production of many natural products [21,40,41].
This screen has the potential to be applied to the endophytes of
other TCM plant species or growth climates.
PKS and NRPS genes are appropriate targets for detection of
small molecule biosynthesis systems [21,40,41]. Genetic screening
results demonstrated the presence of at least one NRPS/PKS
biosynthetic pathway in 36% (11/30) of the plant DNA extracts.
Furthermore, PKS genes were detected more frequently in the
total DNA samples (30%, 9/30) than NRPS genes (13%, 4/30).
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PKS and NRPS biosynthesis genes have previously been detected
in fungal and bacterial isolates from ecological niches similar to
those inhabited by endophytes. Fungal and bacterial isolates of
sponges (18% and 13.8%, respectively) and marine (90%) and
freshwater (65%) cyanobacteria were positive for PKS and NRPS
genetic screens [23].
Due to the fact that plants are host to diverse endophyte
populations, it was speculated that many of the total DNA extracts
would contain PKS and NRPS genes. However, genetic screening
for endophyte biosynthesis genes has not previously been
attempted using total plant DNA extracts. In this study, DNA
samples often contained only one PKS/NRPS sequence, inferring
that there may be few biosynthesis genes present in the endophytes
Figure 1. Phylogenetic analysis of putative fungal type I PKSs in TCM herbs. Evolutionary relationships were determined by maximum
likelihood analysis using the LG substitution model. Branch lengths indicate inferred divergence of amino acid sequences. Numbers adjacent to the
nodes indicate aLRT support, with support values .50% considered to be significant. Accession numbers for sequences obtained from GenBank are
indicated. The scale bar represents 0.2 amino acid changes.
doi:10.1371/journal.pone.0035953.g001
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of the sampled plants. It is probable that only a few endophytes
biosynthesize compounds that increase plant viability, and these
endophytes may dominate the population, and any PCR results.
Additionally, many samples failed to reveal any endophyte PKS or
NRPS genes. This indicates that either endophytes within the
samples did not contain PKS or NRPS biosynthesis genes or that
the biosynthesis gene sequences were too divergent to be amplified
by the reaction described. Alternatively, endophytes involved in
the biosynthesis of bioactive compounds in these plants may have
been absent from the tissue type used for the DNA extractions
[42]. Instead endophytes could inhabit an alternate host tissue and
export bioactive compounds for storage in the tissue used
medicinally [43].
Actinobacteria, in particular Streptomyces sp., are significant
secondary metabolite producers, synthesising a functionally diverse
class of bioactive compounds, often through PKS and NRPS
pathways [44,45]. Although Actinobacteria are only a subset of the
total bacterial population, sequences related to non-actinobacteria
NRPS genes were also detected using the actinobacterial primers
(Figure 4). This is possible, due to the conserved gene regions
within the KS and A domains [46]. However, the type I PKS and
NRPS primers used in this study cannot amplify all PKS or NRPS
genes, suggesting that these primers underestimate endophytes’
KS and NRPS gene diversity within the plants. This limitation is
in part due to the absence of divergent sequences in the sequence
databases and primers which are not designed to detect atypical
PKS or NRPS genes. Consequently, some interesting pathways
Figure 2. Phylogeny of fungal NRPSs. Relationships inferred by maximum likelihood analysis of fungal NRPS adenylation domain fragments
using the WAG substitution model. Branch lengths indicate inferred divergence of amino acid sequences. Numbers adjacent to nodes indicate aLRT
support, with support values .50% considered significant. Bacterial and fungal reference sequences are included in the analysis and the accession
numbers for these sequences obtained from GenBank are indicated. The scale bar represents 0.2 amino acid changes.
doi:10.1371/journal.pone.0035953.g002
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may be overlooked with this approach. Sequence-based approach-
es will improve from advances in our understanding of the
molecular genetics of PKS and NRPS biosynthesis.
Phylogenetic analysis of putative fungal KS domains showed
that sequences clustered into two main groups (Figure 1). PKSs
which synthesize partially reduced polyketides, such as lovastatin
and T-toxin, were clustered separately from those PKSs that
synthesize unreduced polyketides, examples of which include
aflatoxin and melanin. This division is supported by previous
phylogenetic investigations of fungal PKSs [47,48]. All ten
sequences from the TCM samples were within the cluster of
PKSs that synthesize unreduced polyketides, specifically, pigments.
Fungal pigments show a range of bioactivities such as elsinchrome,
which possesses phytotoxic activities [49], and the napthopyrones,
which possess antimicrobial activities [50,51]. It can be concluded
that the detection of pigment-type biosynthesis genes indicates the
biosynthetic potential of TCM endophytes. The putative fungal
KS domain fragments identified; BS1, CF1, LH1, LH2, SS1, SS3
and TB1, showed close relationships with KS domains of
symbiotic fungi, including endophytes and mycobionts of lichens
(Figure 1). These amplified KS domains may encode biosynthetic
pathways unique to symbiotic fungi and thus be involved in the
host-symbiont relationship.
Phylogenetic analysis of the fungal A domains demonstrated
that the sequences were clustered with NRPSs from bacteria
(Figure 2). Some sequences showed similarity to bacterial PKS
sequences involved in the production of cyclic lipopeptides, such as
arthrofactin synthetases (Table 3). Cyclic lipopeptide production
by Pseudomonas fluorescens was shown to play a key role in biofilm
formation, motility and the antifungal activity of strain SBW25.
Thus the detected fungal A domains could be involved in the
biosynthesis of novel fungal peptides. The amplified A domains
were related to NRPS pathways involved in the synthesis of
compounds with a range of bioactivities; microginin, an angio-
tensin-converting enzyme inhibitor [52], anabaenopeptin, a serine
protease inhibitor [53], and aeruginosin, a thrombin inhibitor
[54]. Protease inhibitor-type compounds are significant because of
the biochemical processes they control. For example serine
Figure 3. Phylogeny of bacterial type I PKSs. Relationships inferred by maximum likelihood analysis of bacterial PKS ketosynthase domain
fragments, using the LG substitution model. Branch length indicates inferred divergence of amino acid sequences and numbers adjacent to the
nodes indicate aLRT support, with support values.50% considered significant. The accession numbers for all sequences obtained from GenBank are
indicated. The scale bar represents 0.2 amino acid changes.
doi:10.1371/journal.pone.0035953.g003
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protease inhibitors possess cell cytotoxic activities and are used for
the treatment of a wide variety of human diseases [55].
Sequences identified from the bacterial NRPS screen were
phylogenetically grouped with diverse bacterial NRPS biosynthesis
pathways. The sequences LH3 and LH4 were grouped with
proteobacterial NRPSs involved in the synthesis of the side-
rophores pyoverdine and enterobactin [56,57]; antibiotics, masse-
tolide A and virginiamycin [58,59]; and the biosurfactant,
arthrofactin [60]. It appears that these putative A domain genes
could be involved in the synthesis of novel and biologically active
peptides, which in turn add to the medicinal activity of the host
plants. Gene fragments BC1 and BC2 were related to an A
domain of an uncharacterized NRPS pathway of Rhodococcus
erythropolis. While this specific NRPS gene is uncharacterized,
Rhodococcus spp. are known to contain a large set of NRPS and
PKS genes with their biotechnological significance arising from
their existence in harsh environmental niches [61,62]. It is
proposed that the products of this NRPS may assist endophytes
to survive inside the plant. The putative A domain sequence DL3
failed to cluster with known NRPSs and therefore may represent
divergent NRPSs, for the production of unique peptide-derived
compounds.
Of interest in the phylogenetic analysis of bacterial PKS
fragments, is that fragments PPol1 and PPol2 grouped with
various enzymes of Streptomyces hygroscopicus involved in geldana-
mycin biosynthesis. This suggests that the endophyte genes could
encode pathways for the production of similar anticancer
antibiotics [63]. The detection of endophyte associated biosynthe-
Figure 4. Phylogeny of bacterial NRPS sequences. Relationships inferred by maximum likelihood analysis of bacterial NRPS adenylation domain
fragments using the LG substitution model. Branch lengths indicate inferred divergence of amino acid sequences. Numbers adjacent to the nodes
indicate aLRT support, with support values .50% considered significant. The accession numbers for all sequences obtained from GenBank are
indicated. The scale bar represents 0.5 amino acid changes.
doi:10.1371/journal.pone.0035953.g004
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sis genes in P. polyphylla highlights the fact that this plant is a good
candidate for further endophyte investigations involved in isolation
endophyte and characterisation of their associated bioactive
compounds. Endophytes offer sustainable production of plant
associated natural products, and have undeniable application in
the development of compounds in drug discovery [64].
In summary, TCM herbs are host to diverse bacteria and fungi
with the potential to synthesize secondary metabolites which
would contribute to the plant’s chemical composition. In this
particular study, genetic screening revealed endophyte-derive PKS
and NRPS fragments with putative roles in the biosynthesis of
secondary metabolites with a wide array of biological activities.
This screening allows further investigations to focus on plants that
host endophytes with the greatest potential to produce polykletide
and nonribosomal peptide-based bioactive substances. To further
investigate links between PKS/NRPS genes and bioactivity,
elucidation of the full biosynthetic pathways is required from
endophytes. Future studies of the plant candidates may lead to
harnessing endophytes, their genetic resources, and associated
compounds which are valuable leads for drug discovery investi-
gations, as well as understanding how endophytes contribute to the
bioactivity of medicinal plants. In addition, it remains to be
determined whether the PKS and NRPS genes identified in this
study are functionally dedicated to specialized endophyte-based
activities.
Supporting Information
Figure S1 Multiple sequence alignments. The multiple
sequence alignments of KS domains protein sequences, from PKS
pathways, and A domain protein sequences, from NRPS
pathways, were generated using ClustalX.
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